Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Laparoscopic Surgery(Electronic Edition) ›› 2024, Vol. 17 ›› Issue (05): 284-289. doi: 10.3877/cma.j.issn.1674-6899.2024.05.006

• Original Articles • Previous Articles     Next Articles

The safety and long-term efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of pancreas divi

Kaixuan Fang1,2,3, Yaqi Zhai2, Guanjun Zhang1,2, Shengxin Chen1,2, Dexin Chen1,2, Wenjing Liu1,2, Yawen Liang1,2, Mingyang Li2,()   

  1. 1.Graduate School,Chinese PLA General Hospital,Beijing 100853,China
    2.Department of Gastroenterology,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China
    3.The 960th Hospital of PLA,Shandong 250031,China
  • Received:2024-08-27 Online:2024-10-30 Published:2024-12-03
  • Contact: Mingyang Li

Abstract:

Objective

To investigate the safety and long-term efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of pancreas divisum.

Methods

A total of 92 patients diagnosed with pancreas divisum in the Department of Gastroenterology, the First Medical Center of PLA General Hospital from Jan. 2010 to Dec. 2023 were retrospectively analyzed, and the inclusion and exclusion criteria were clarified. The clinical data were collected and analyzed, including general condition, operation characteristics, postoperative adverse events and follow-up. The long-term efficacy of endoscopic treatment was evaluated by outpatient follow-up and telephone follow-up.

Results

A total of 76 patients with pancreas divisum who underwent ERCP were enrolled in the study (40 males and 36 females), with an average age of(40.9±17.5) years. ERCP was successfully performed in 66 of the 76 patients, with a technical success rate of 86.8% (66/76). The incidence of ERCP-related adverse events was 12.8% (21/164), including 16 cases of post-ERCP pancreatitis, 4 cases of infection, and 1 case of bleeding. ERCP was performed for 151 times in 66 patients, with a median of 2 times (1-6 times). During a median follow-up of 110 months (9-160 months), 53 patients (80. 3%, 53/66) achieved long-term remission.

Conclusion

The endoscopic retrograde cholangiopancreatography (ERCP) demonstrates favorable safety profile and long-term efficacy in the management of pancreas divisum, making it a viable first-line treatment option.

Key words: Pancreas divisum, Pancreatitis, Endoscopic Retrograde Cholangiopancreatography(ERCP), Endoscopy, Treatment

京ICP 备07035254号-20
Copyright © Chinese Journal of Laparoscopic Surgery(Electronic Edition), All Rights Reserved.
Tel: 01066937562 E-mail: zhonghuaqiangjing@126.com
Powered by Beijing Magtech Co. Ltd